Press release
Segmentation, Major Trends, and Competitive Overview of the mRNA Therapeutics CDMO Market
mRNA Therapeutics CDMO Market
Forecasted Growth and Market Size of the mRNA Therapeutics CDMO Market
The market for mRNA therapeutics CDMOs is anticipated to experience rapid growth, reaching a valuation of $8.26 billion by 2030. This corresponds to a compound annual growth rate (CAGR) of 11.7% during the forecast period. Several factors fuel this expansion, including heightened investments in mRNA therapeutic pipelines, technological progress in plasmid DNA and mRNA synthesis processes, and the rise of cancer immunotherapy along with protein replacement treatments. Additionally, increasing demand for fill-finish capabilities and growing collaborations between biotechnology firms and CDMOs also contribute significantly. Critical trends set to influence the market include rising outsourcing of mRNA development and manufacturing, growing emphasis on lipid nanoparticle (LNP) formulation technologies, expansion of viral vaccine and cancer immunotherapy pipelines, enhanced quality assurance and regulatory compliance, and broader adoption of analytical and bioanalytical laboratory services.
Download a free sample of the mrna therapeutics cdmo market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25841&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Factors Accelerating Demand in the mRNA Therapeutics CDMO Sector
The surge in cancer immunotherapy and protein replacement therapies has notably boosted the requirement for specialized mRNA manufacturing services. These therapeutic approaches rely heavily on sophisticated mRNA production methods, propelling demand for CDMOs capable of handling complex biologics.
Meanwhile, technological advancements in plasmid DNA and mRNA synthesis have streamlined and improved the efficiency of manufacturing processes. This progress has not only enhanced product quality but also reduced production times, attracting more biopharmaceutical companies to outsource their development and manufacturing needs.
The top companies influencing the mRNA Therapeutics CDMO landscape
Several key players dominate the mRNA therapeutics CDMO industry, including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, FUJIFILM Holdings Corporation, Evonik Industries AG, AGC Biologics GmbH, Eurofins Scientific SA, Samsung Biologics Co. Ltd., Wuxi Biologics, Recipharm AB, EMERGENT BioSolutions Inc., Genscript Biotech, Ginkgo Bioworks Holdings Inc., Corden Pharma Corp., TriLink BioTechnologies LLC, Biocina Pty Ltd., Aldevron LLC, Synbio Technologies LLC, etherna manufacturing, Bio-Synthesis Inc., and Biomay AG.
In a notable development from September 2024, Agilent Technologies Inc., a US-based medical equipment firm, acquired BIOVECTRA for $0.925 billion. This strategic acquisition aims to bolster Agilent's CDMO expertise in high-growth therapeutic areas, particularly mRNA therapeutics. BIOVECTRA, based in Canada, brings specialized knowledge in biologics and advanced pharmaceutical manufacturing, enriching Agilent's service portfolio.
View the full mrna therapeutics cdmo market report:
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-cdmo-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Innovations and Cutting-edge Trends Emerging in the mRNA Therapeutics CDMO Market
The mRNA therapeutics CDMO industry is witnessing a growing focus on innovative approaches such as in situ nanomedicine vaccines. These next-generation mRNA-based therapies are designed to create nanomedicines directly within the patient's body, enabling targeted delivery and tailored immune activation through engineered transgene expression.
For example, in January 2025, Esphera SynBio Inc., a biotechnology firm based in Canada, initiated a new project supported by the CQDM Quantum Leap program. This initiative aims to improve first-generation lipid nanoparticle or messenger RNA (LNP/mRNA) vaccines by incorporating proprietary transgene designs that promote the in vivo production of immunostimulatory nanomedicines. Such advances promise precise antigen delivery and customized immune responses, signaling a major breakthrough in vaccine technology.
Breakdown of Key Segments in the mRNA Therapeutics CDMO Market
This report categorizes the mRNA therapeutics CDMO market into the following segments:
1) By Type of Service: Development Services, Manufacturing Services, Laboratory Services
2) By Indication: Infectious Diseases, Metabolic and Genetic Diseases, Cardiovascular and Cerebrovascular Diseases
3) By Application: Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies
4) By End User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Research Organizations
Further detailed subsegments include:
Development Services: Process Development, Analytical Method Development, Formulation Development, Regulatory Support
Manufacturing Services: Plasmid DNA Manufacturing, mRNA Synthesis, Lipid Nanoparticle (LNP) Formulation, Fill-Finish Services
Laboratory Services: Quality Control Testing, Stability Testing, Bioanalytical Testing, Preclinical Testing
Together, these classifications offer a comprehensive view of the market landscape, highlighting the diverse service offerings and application areas driving the growth of the mRNA therapeutics CDMO sector.
Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Segmentation, Major Trends, and Competitive Overview of the mRNA Therapeutics CDMO Market here
News-ID: 4595187 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Overview of the Nanomaterials Market …
Exploring the future outlook of nanomaterials in personalized medicine reveals a rapidly evolving landscape driven by advancements in healthcare technology. As personalized treatment approaches gain traction, nanomaterials are positioned to play a crucial role in enhancing diagnostic and therapeutic precision. This overview delves into the market's growth forecast, key players, ongoing trends, and detailed segmentation to provide a comprehensive understanding of this transformative sector.
Anticipated Growth Trajectory of the Nanomaterials in…
Analysis of Segments and Major Growth Areas in the Myeloproliferative Disorders …
The myeloproliferative disorders drugs market is poised for steady growth as advances in targeted therapies and expanding healthcare infrastructure continue to shape its trajectory. With ongoing research and increasing investments, the sector is evolving rapidly, presenting new opportunities for personalized treatments and rare blood disorder management. Let's explore the market's forecast, key players, emerging trends, and segment details to get a comprehensive understanding of this dynamic field.
Forecasted Global Size and…
Competitive Landscape: Leading Companies and New Entrants in the Myc Proto Oncog …
Exploring the future landscape of the myc proto oncogene protein market reveals substantial growth potential driven by technological advancements and increased research activities. This sector is rapidly evolving as innovations in biotechnology and pharmaceutical research expand the applications and effectiveness of myc-related products.
Projected Market Growth and Key Drivers for the Myc Proto Oncogene Protein Market
The myc proto oncogene protein market is poised for significant expansion, expected to reach…
Emerging Growth Trends Driving Expansion in the Multivitamin Capsules and Tablet …
The multivitamin capsules and tablets market is set for significant expansion in the coming years as consumers increasingly seek tailored nutritional solutions. Advancements in supplement formulations and growing awareness around preventive healthcare are expected to play pivotal roles in shaping this market's future. Let's explore the current market value, key players, prevailing trends, and the primary segments driving this growth.
Projected Market Value and Growth Trajectory of the Multivitamin Capsules and…
More Releases for RNA
Small Interfering RNA (siRNA) Therapeutics Market Growth (2026-2033) | RNA Drugs …
DataM Intelligence has released a new research report titled "Small Interfering RNA (siRNA) Therapeutics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market…
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
